Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
PUR-WASH vs PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
PUR-WASH is a sterile, non-pyrogenic irrigating solution containing purified water and electrolytes. Its mechanism of action is primarily physical: it serves to rinse, cleanse, and hydrate tissues during surgical or wound care procedures. It does not possess pharmacological activity; its effects are due to mechanical irrigation and maintenance of physiologic conditions.
Replacement of extracellular fluid and electrolytes; provides buffering capacity via bicarbonate precursor (acetate) and maintains physiological p H.
Sterile irrigation of body cavities, wounds, and surgical sites,Cleansing of wounds and burns,Rinsing of instruments and equipment,Hydration of tissues during surgical procedures
Intravenous replacement of intravascular volume and electrolytes in patients with normal or slightly acidic p H,Maintenance of fluid and electrolyte balance during surgery or in critical care,Correction of hypovolemia when isotonic fluid administration is appropriate
Not applicable; PUR-WASH is a sterile irrigating solution for topical use only, not for systemic administration. No standard systemic dose.
Intravenous infusion, rate adjusted based on clinical status and electrolyte needs; typical adult dose is 500-1000 m L over 1-2 hours.
Terminal elimination half-life is 12-18 hours (mean 15 h). In patients with moderate renal impairment (Cr Cl 30-50 m L/min), half-life may extend to 24-30 hours; severe impairment (Cr Cl <30 m L/min) may prolong to >40 hours, requiring dose adjustment.
Not applicable; components follow first-order kinetics with rapid redistribution. Lactate half-life ~15-30 minutes (hepatic metabolism).
PUR-WASH is not metabolized; it is absorbed and excreted unchanged by the kidneys if administered intravenously or absorbed from wounds. When used topically or for irrigation, minimal systemic absorption occurs.
Acetate is metabolized primarily in the liver and muscles to bicarbonate.
Primarily renal excretion of unchanged drug (85-90%), with 10-15% fecal elimination via biliary secretion.
Primarily renal; >95% of infused ions (sodium, chloride, lactate, calcium, magnesium) are excreted unchanged in urine. Biliary/fecal elimination negligible (<1%).
Approximately 98% bound primarily to albumin; minor binding to alpha-1-acid glycoprotein (AAG).
Negligible (<1%); ions are free in plasma (no significant protein binding).
Vd = 0.3-0.5 L/kg, indicating moderate distribution into total body water; higher Vd observed in obesity (0.6 L/kg) due to lipophilicity.
0.4 L/kg; distributes mainly in extracellular fluid (ECF).
Oral: 95-100% (first-pass metabolism negligible); Intramuscular: 100%; Subcutaneous: 90-95% (site-dependent).
100% (intravenous); not absorbed orally.
No systemic absorption; not applicable.
Contraindicated in oliguric or anuric renal failure; in GFR <30 m L/min, avoid use or monitor electrolytes closely; no specific GFR-based dose adjustment.
No systemic absorption; not applicable.
No specific Child-Pugh based adjustments; use with caution in hepatic impairment due to risk of fluid overload.
No systemic absorption; use as directed for wound irrigation per local protocol.
Weight-based dosing: 5-10 m L/kg intravenous infusion over 1-2 hours, not to exceed 30 m L/kg/day.
No systemic absorption; use as directed for wound irrigation per local protocol.
Use with caution due to increased risk of fluid overload and electrolyte imbalance; adjust rate and volume based on renal function and comorbidities, typical initial dose 500 m L over 2-3 hours.
None
None.
For external use only. Not for injection. Use only if solution is clear and container undamaged. Discard unused portion. Do not use for irrigation of closed cavities without adequate drainage. Monitor fluid and electrolyte balance when large volumes are used, especially in patients with renal impairment or cardiac failure. Prolonged contact with tissues may cause maceration.
Use with caution in patients with severe renal impairment, heart failure, or conditions associated with sodium retention,Monitor serum electrolytes, fluid balance, and acid-base status during prolonged administration,Risk of volume overload in patients with compromised cardiac or renal function,Contains aluminum; may be toxic with prolonged use in patients with renal impairment
Hypersensitivity to any component. Do not use for irrigation of body cavities where absorption may lead to fluid overload or electrolyte disturbances without appropriate monitoring. Not for intravascular or intrathecal use.
Hypersensitivity to any component,Severe hypernatremia or severe hyperchloremia,Severe metabolic alkalosis,Patients with contraindications to intravenous fluid administration
None relevant as PUR-WASH is a topical irrigating solution with no systemic absorption.
No food interactions are relevant as Physiosol p H 7.4 is not ingested. It is used exclusively for topical irrigation during medical procedures.
PUR-WASH has not been formally studied in pregnant women. Animal studies are lacking. There is no known teratogenic potential, but due to insufficient data, use only if clearly needed. No specific trimester risks have been identified.
Physiosol p H 7.4 (balanced electrolyte solution) is considered low risk for teratogenicity. There are no known fetal risks associated with its use in any trimester, as it is a physiological solution. However, large volumes or rapid administration could theoretically cause maternal electrolyte imbalances, which may indirectly affect the fetus.
It is unknown whether PUR-WASH is excreted in human breast milk. The M/P ratio has not been determined. Caution is advised; consider the developmental and health benefits of breastfeeding along with the mother's clinical need.
Physiosol p H 7.4 is compatible with breastfeeding. No M/P ratio is available; however, components are normal plasma constituents and unlikely to be excreted into breast milk in clinically significant amounts.
No pharmacokinetic studies have been performed in pregnant women. Currently, no dose adjustment is recommended for PUR-WASH during pregnancy, but caution is warranted due to limited data.
No specific dose adjustment is required for pregnancy. However, consider increased plasma volume and glomerular filtration rate in pregnancy; standard dosing is appropriate, but monitor for volume overload.
PUR-WASH is a sterile, preservative-free irrigating solution indicated for wound cleansing and debridement. Use at room temperature to avoid thermal injury. Do not use for prolonged irrigation of closed body cavities due to risk of fluid absorption. For external wounds only; not for injection or ophthalmic use.
Physiosol p H 7.4 is a balanced crystalloid solution used for irrigation, not for systemic administration. In the operating room, it is preferred for peritoneal lavage due to its neutral p H, which minimizes tissue irritation. Do not use for intravenous infusion; verify labeling to avoid confusion with IV solutions. Warm to body temperature before use to prevent hypothermia during large-volume irrigation.
Do not ingest or inject this solution; it is for external wound cleaning only.,Discard any unused portion after opening; do not reuse or store opened bottles.,Do not apply heat or microwave the solution to avoid burns.,Use within 24 hours of opening to maintain sterility.,If irritation or infection occurs, stop use and consult your healthcare provider.
This solution is used to rinse body cavities during surgery, not for intravenous use.,You may feel a cooling sensation during irrigation; this is normal.,Report any signs of infection at the surgical site, such as redness, swelling, or discharge.,Do not attempt to use this solution at home; it is for hospital use only.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about PUR-WASH vs PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER, answered by our medical review team.
PUR-WASH is a Irrigation Solution that works by PUR-WASH is a sterile, non-pyrogenic irrigating solution containing purified water and electrolytes. Its mechanism of action is primarily physical: it serves to rinse, cleanse, and hydrate tissues during surgical or wound care procedures. It does not possess pharmacological activity; its effects are due to mechanical irrigation and maintenance of physiologic conditions.. PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER is a Irrigation Solution that works by Replacement of extracellular fluid and electrolytes; provides buffering capacity via bicarbonate precursor (acetate) and maintains physiological p H.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between PUR-WASH and PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER depend on the specific clinical indication. These are both Irrigation Solution agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of PUR-WASH is: Not applicable; PUR-WASH is a sterile irrigating solution for topical use only, not for systemic administration. No standard systemic dose.. The standard adult dose of PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER is: Intravenous infusion, rate adjusted based on clinical status and electrolyte needs; typical adult dose is 500-1000 m L over 1-2 hours.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between PUR-WASH and PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. PUR-WASH is classified as Category C. PUR-WASH has not been formally studied in pregnant women. Animal studies are lacking. There is no known teratogenic potential, but due to insufficient data, use only if clearly nee. PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER is classified as Category C. Physiosol pH 7.4 (balanced electrolyte solution) is considered low risk for teratogenicity. There are no known fetal risks associated with its use in any trimester, as it is a phys. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.